Eiichi Araki
#151,789
Most Influential Person Now
Researcher ORCID ID = 0000-0002-4064-7525
Eiichi Araki's AcademicInfluence.com Rankings
Eiichi Arakicomputer-science Degrees
Computer Science
#8047
World Rank
#8466
Historical Rank
Computational Linguistics
#1725
World Rank
#1743
Historical Rank
Machine Learning
#3181
World Rank
#3220
Historical Rank
Artificial Intelligence
#3484
World Rank
#3534
Historical Rank
Download Badge
Computer Science
Eiichi Araki's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Eiichi Araki Influential?
(Suggest an Edit or Addition)Eiichi Araki's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. (1995) (2533)
- Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus (2010) (1938)
- Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein (1991) (1486)
- Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene (1994) (1285)
- Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. (2002) (918)
- International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values (2012) (885)
- Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. (2007) (776)
- Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway (2001) (602)
- AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer (2006) (516)
- Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells (2002) (468)
- Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. (2006) (458)
- Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. (2001) (425)
- Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. (2006) (387)
- Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. (2003) (355)
- Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. (1992) (345)
- Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. (1987) (300)
- Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells (2003) (285)
- Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression (2005) (257)
- Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. (2002) (250)
- Japanese Clinical Practice Guideline for Diabetes 2019 (2020) (243)
- 4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice (*) (1995) (229)
- Japanese Clinical Practice Guideline for Diabetes 2016 (2018) (222)
- Erratum: Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene (Nature (1994) 372 (186-190)) (1994) (210)
- Endoplasmic reticulum stress and diabetes mellitus. (2003) (204)
- Statins Activate Peroxisome Proliferator-Activated Receptor γ Through Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase–Dependent Cyclooxygenase-2 Expression in Macrophages (2007) (198)
- Japanese Clinical Practice Guideline for Diabetes 2019 (2020) (188)
- Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial (2018) (176)
- Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. (2003) (173)
- Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study (2014) (169)
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial (2018) (164)
- SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. (2014) (163)
- Impact of Endoplasmic Reticulum Stress Pathway on Pancreatic β-Cells and Diabetes Mellitus (2003) (161)
- Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. (2003) (144)
- Cyclooxygenase-2 Inhibitor NS-398 Protects Neuronal Cultures From Lipopolysaccharide-Induced Neurotoxicity (2001) (137)
- Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial (2019) (123)
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial. (2016) (123)
- Oxidative stress: A cause and therapeutic target of diabetic complications (2010) (121)
- Impact of Mitochondrial Reactive Oxygen Species and Apoptosis Signal–Regulating Kinase 1 on Insulin Signaling (2006) (112)
- Human Skeletal Muscle Insulin Receptor Substrate-1: Characterization of the cDNA, Gene, and Chromosomal Localization (1993) (108)
- Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator‐controlled, double‐blind study (2012) (107)
- Japanese Clinical Practice Guideline for Diabetes 2016 (2018) (107)
- Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial (2018) (106)
- A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians (2008) (104)
- [Mitochondrial reactive oxygen species]. (2016) (100)
- Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus (2017) (98)
- Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. (2003) (98)
- Kif26b, a kinesin family gene, regulates adhesion of the embryonic kidney mesenchyme (2010) (98)
- Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial. (2017) (96)
- Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase (2000) (95)
- Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study. (2000) (93)
- Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice. (2005) (92)
- Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. (2007) (91)
- Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway* (2005) (90)
- The insulin receptor and its substrate: molecular determinants of early events in insulin action. (1993) (90)
- Characterization of the promoter region of the human insulin receptor gene. Evidence for promoter activity. (1987) (88)
- Impact of mitochondrial ROS production on diabetic vascular complications. (2007) (87)
- Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. (1998) (86)
- Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia. (2017) (83)
- Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. (1998) (81)
- TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis. (2009) (80)
- A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. (1991) (80)
- Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. (2009) (78)
- Mild Electrical Stimulation with Heat Shock Ameliorates Insulin Resistance via Enhanced Insulin Signaling (2008) (75)
- Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials (2014) (74)
- Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1 (2016) (73)
- Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats. (2000) (70)
- Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study (2015) (68)
- Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. (2004) (68)
- Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial (2018) (68)
- Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 β-cell line. (2011) (67)
- pSV00CAT: low background CAT plasmid. (1988) (66)
- Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. (1994) (63)
- Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. (2005) (63)
- Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines (2002) (62)
- Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway (1996) (62)
- Impact of Natural IRS-1 Mutations on Insulin Signals: Mutations of IRS-1 in the PTB Domain and Near SH2 Protein Binding Sites Result in Impaired Function at Different Steps of IRS-1 Signaling (1997) (62)
- Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. (2001) (61)
- Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-α (PPARα) and PPARγ through MAPK-dependent COX-2 Expression in Macrophages* (2008) (59)
- Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. (2002) (59)
- Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes (2003) (58)
- Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells. (1999) (58)
- Characterization of the promoter region of the human insulin receptor gene. (1989) (53)
- Atypical Bartter syndrome with sensorineural deafness with G47R mutation of the beta-subunit for ClC-Ka and ClC-Kb chloride channels, barttin. (2003) (53)
- Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: report of Committee on Causes of Death in Diabetes Mellitus (2017) (50)
- Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene (1994) (49)
- Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice (2016) (47)
- Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice. (2011) (47)
- Long‐term treatment with empagliflozin as add‐on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus (2015) (47)
- Possible involvement of atypical protein kinase C (PKC) in glucose-sensitive expression of the human insulin gene: DNA-binding activity and transcriptional activity of pancreatic and duodenal homeobox gene-1 (PDX-1) are enhanced via calphostin C-sensitive but phorbol 12-myristate 13-acetate (PMA) an (1999) (46)
- FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism (2019) (46)
- The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling (2014) (45)
- New glycemic targets for patients with diabetes from the Japan Diabetes Society (2016) (45)
- Hyperthermia With Mild Electrical Stimulation Protects Pancreatic β-Cells From Cell Stresses and Apoptosis (2012) (45)
- Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage Proliferation* (2009) (43)
- Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period (2016) (42)
- The gene for hepatocyte nuclear factor (HNF)‐4α is activated by glucocorticoids and glucagon, and repressed by insulin in rat liver (2000) (42)
- Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. (2008) (41)
- The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver. (2011) (41)
- A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland. (2003) (41)
- Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitus. (2012) (41)
- Insulin stimulates tyrosine phosphorylation of multiple high molecular weight substrates in Fao hepatoma cells. (1992) (40)
- Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy (2014) (40)
- Novel function of transthyretin in pancreatic alpha cells (2012) (38)
- A carboxy-terminal truncation of human alpha-galactosidase A in a heterozygous female with Fabry disease and modification of the enzymatic activity by the carboxy-terminal domain. Increased, reduced, or absent enzyme activity depending on number of amino acid residues deleted. (1996) (38)
- Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment (2019) (38)
- A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy. (2006) (35)
- Molecular scanning of the insulin receptor substrate.1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms (1996) (35)
- Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. (2013) (34)
- A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases. (2010) (34)
- Nifedipine Induces Peroxisome Proliferator-Activated Receptor-&ggr; Activation in Macrophages and Suppresses the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice (2010) (34)
- Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. (2007) (33)
- Cloning of the mouse insulin receptor substrate-1 (IRS-1) gene and complete sequence of mouse IRS-1. (1994) (33)
- Identification of microRNA that represses IRS-1 expression in liver (2018) (32)
- An acylic polyisoprenoid derivative, geranylgeranylacetone protects against visceral adiposity and insulin resistance in high-fat-fed mice. (2010) (32)
- Characterization and regulation of the mouse insulin receptor substrate gene promoter. (1995) (32)
- Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia. (2018) (31)
- Non-invasive measurement of skin autofluorescence to evaluate diabetic complications (2016) (31)
- New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulin-dependent phosphorylation of synapsin I in insulin exocytosis. (2003) (31)
- Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-&ggr; in Macrophages (2011) (30)
- Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes (2013) (29)
- A sensitive and specific assay for dipeptidyl-aminopeptidase II in serum and tissues by liquid chromatography-fluorometry. (1985) (29)
- What is artificial endocrine pancreas? Mechanism and history. (2009) (29)
- Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion (1995) (28)
- Efficacy and safety of dapagliflozin over 1 year as add‐on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial (2017) (28)
- Metabolic disorders in diabetes mellitus: impact of mitochondrial function and oxidative stress on diabetes and its complications. (2006) (28)
- Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study (2019) (28)
- Low glucose induces mitochondrial reactive oxygen species via fatty acid oxidation in bovine aortic endothelial cells (2017) (28)
- Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas (2003) (28)
- Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance (2018) (27)
- Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes (2013) (27)
- Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms (2004) (27)
- AICAR, an activator of AMP-activated protein kinase, down-regulates the insulin receptor expression in HepG2 cells. (2005) (26)
- Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy (2016) (26)
- Long‐term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes (2013) (26)
- Transcription factor AP-2beta: a negative regulator of IRS-1 gene expression. (2010) (26)
- Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice. (2011) (25)
- Mild electrical stimulation increases ubiquitinated proteins and Hsp72 in A549 cells via attenuation of proteasomal degradation. (2008) (25)
- Efficacy and Safety of Semaglutide Once-Weekly vs. Placebo as Add-on to Basal Insulin Alone or in Combination with Metformin in Subjects with Type 2 Diabetes (SUSTAIN 5) (2016) (25)
- Cell-Specific Regulation of IRS-1 Gene Expression: Role of E Box and C/EBP Binding Site in HepG2 Cells and CHO Cells (1997) (25)
- Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophages. (2013) (24)
- Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT‐2 study): 52‐week results from a randomized controlled trial (2020) (24)
- A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study) (2016) (24)
- Mild Electrical Stimulation with Heat Shock Reduces Visceral Adiposity and Improves Metabolic Abnormalities in Subjects with Metabolic Syndrome or Type 2 Diabetes: Randomized Crossover Trials (2014) (23)
- Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus. (2002) (23)
- Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis (2018) (23)
- Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation. (2015) (22)
- Heat shock response regulates insulin sensitivity and glucose homeostasis: pathophysiological impact and therapeutic potential. (2011) (22)
- Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: Insulin secretion in response to physiological concentrations of glucose (1998) (22)
- Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways. (2000) (21)
- Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination (2019) (21)
- Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas (2004) (21)
- Glucose uptake in rat skeletal muscle L6 cells is increased by low-intensity electrical current through the activation of the phosphatidylinositol-3-OH kinase (PI-3K) / Akt pathway. (2011) (21)
- CHOP deletion does not impact the development of diabetes but suppresses the early production of insulin autoantibody in the NOD mouse (2011) (21)
- The phosphatase Dullard negatively regulates BMP signalling and is essential for nephron maintenance after birth (2013) (20)
- One‐hour oral glucose tolerance test plasma glucose at gestational diabetes diagnosis is a common predictor of the need for insulin therapy in pregnancy and postpartum impaired glucose tolerance (2018) (20)
- Insulin receptor activation through its accumulation in lipid rafts by mild electrical stress (2013) (19)
- Anti-atherosclerotic potential of dihydropyridine calcium channel blockers. (2012) (19)
- Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13-p12 in Japanese (2004) (19)
- Impaired balance is related to the progression of diabetic complications in both young and older adults. (2017) (19)
- Development of a highly responsive needle-type glucose sensor using polyimide for a wearable artificial endocrine pancreas (2006) (19)
- Analysis of vasopressin receptor type II (V2R) gene in three Japanese pedigrees with congenital nephrogenic diabetes insipidus: identification of a family with complete deletion of the V2R gene. (1996) (19)
- Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan (2021) (18)
- Preclinical Cushing’s Syndrome Resulting from Black Adrenal Adenoma (2004) (16)
- Identification of a cis-acting element and a novel trans-acting factor of the human insulin receptor gene in HepG2 and rat liver cells. (2001) (15)
- Mild Electrical Stimulation Increases Stress Resistance and Suppresses Fat Accumulation via Activation of LKB1-AMPK Signaling Pathway in C. elegans (2014) (14)
- Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies (2020) (14)
- Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes. (2020) (14)
- 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB. (2004) (14)
- A novel combination of mild electrical stimulation and hyperthermia: General concepts and applications (2009) (13)
- Heat shock treatment with mild electrical stimulation safely reduced inflammatory markers in healthy male subjects. (2010) (13)
- Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes (2018) (13)
- Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial (2019) (13)
- A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide. (2005) (12)
- [Type 2 diabetes and impaired glucose tolerance]. (2013) (12)
- The Role of Heat Shock Response in Insulin Resistance and Diabetes (2014) (12)
- Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial (2019) (12)
- The effect of group‐based lifestyle interventions on risk factors and insulin resistance in subjects at risk for metabolic syndrome: the Tabaruzaka Study 1 (2010) (12)
- IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance. (2007) (12)
- Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes (2011) (12)
- Differential predictive factors for cardiovascular events in patients with or without cancer history (2019) (12)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients. (2010) (11)
- Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2. (2007) (11)
- Mechanism‐based antioxidant therapies promise to prevent diabetic complications? (2013) (11)
- Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ. (2019) (11)
- Activation of heat shock response to treat obese subjects with type 2 diabetes: a prospective, frequency-escalating, randomized, open-label, triple-arm trial (2016) (10)
- A rare case showing subacute thyroiditis-like symptoms with amyloid goiter after anti-tumor necrosis factor therapy (2015) (10)
- Impacts of the 2016 Kumamoto Earthquake on glycemic control in patients with diabetes (2018) (10)
- New glycemic targets for patients with diabetes from the Japan Diabetes Society (2016) (9)
- Hypoglycemia induces mitochondrial reactive oxygen species production through increased fatty acid oxidation and promotes retinal vascular permeability in diabetic mice. (2020) (9)
- Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes - A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society. (2020) (9)
- A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Indicated Significant Improvement in Glycemic and Liver Function-related Parameters (2018) (8)
- The clinical course and pathophysiological investigation of adolescent gestational diabetes insipidus: a case report (2018) (8)
- Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials (2021) (8)
- A case of insulin autoimmune syndrome with HLA DRB1*0404: impact on the hypothesis for the molecular pathogenesis involving DRB1 molecules (2006) (8)
- Impact of hepatic HSP72 on insulin signaling. (2019) (7)
- Abstract 13374: Efficacy and Safety of K-877, a Potent and Selective PPAR-α Modulator (SPPARMα), in Combination With Statins in Japanese Patients With Dyslipidemia (2015) (7)
- Baseline plasma aldosterone level and renin activity allowing omission of confirmatory testing in primary aldosteronism. (2020) (7)
- 985-P: Oral Semaglutide as Add-On to Insulin in T2D: PIONEER 8 (2019) (7)
- Semaglutide Reduces HbA1c Across Baseline HbA1c Subgroups Across SUSTAIN 1–5 Clinical Trials (2017) (7)
- Inhibition of inflammation-mediated DPP-4 expression by linagliptin increases M2 macrophages in atherosclerotic lesions. (2020) (7)
- Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues. (2008) (7)
- Relationship between lifestyle and lifestyle-related factors in a rural–urban population of Japan (2013) (7)
- The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes (2016) (7)
- Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination (2013) (7)
- [Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species]. (2008) (7)
- Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society (2020) (6)
- Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate (2021) (6)
- Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma (2016) (6)
- [Insulin receptor substrate-1 (IRS-1) gene]. (1997) (6)
- Hyperemesis gravidarum followed by refeeding syndrome causes electrolyte abnormalities induced rhabdomyolysis and diabetes insipidus. (2019) (6)
- New classification and diagnostic criteria for insulin resistance syndrome (2022) (6)
- An intervention study to promote self-improvement of lifestyle in a Japanese community: a new health support program (2011) (6)
- Abstract 15652: Comparison of the Novel Peroxisome Proliferator-Activated Receptor Alpha Agonist K-877 and Fenofibrate on High-Density Lipoprotein Subclass Distribution Determined by High-Performance Liquid Chromatography in Patients With Dyslipidemia (2013) (5)
- Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT‐2 study (2021) (5)
- Involvement of advanced glycation end‐products in ‘hyperglycemic memory’ (2015) (5)
- Prevalence of metabolic syndrome in stroke patients: a prospective multicenter study in Japan (2014) (5)
- Predictors of coronary heart disease in Japanese patients with type 2 diabetes: Screening for coronary artery stenosis using multidetector computed tomography (2010) (5)
- The impact of Ca²⁺/calmodulin-dependent protein kinase II on insulin gene expression in MIN6 cells. (2012) (5)
- Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry) (2021) (5)
- Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes—DEPICT-2 Study (2018) (5)
- Mineralocorticoid Receptor May Regulate Glucose Homeostasis through the Induction of Interleukin-6 and Glucagon-Like peptide-1 in Pancreatic Islets (2019) (5)
- Effects of olmesartan, an angiotensin II receptor blocker, on peripheral insulin sensitivity in Japanese subjects with type 2 diabetes and hypertension. (2012) (5)
- [Diabetes mellitus and endoplasmic reticulum stress]. (2003) (4)
- A case of cortisol producing adrenal adenoma associated with a latent aldosteronoma: usefulness of the ACTH loading test for the detection of covert aldosteronism in overt Cushing syndrome. (2012) (4)
- Regulation of TNFα converting enzyme activity in visceral adipose tissue of obese mice. (2013) (4)
- Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials (2021) (4)
- Thiazolidinedione‐independent activation of peroxisome proliferator‐activated receptor γ is a potential target for diabetic macrovascular complications (2011) (4)
- Regulation of the insulin gene transcription by glucose. (2002) (4)
- [Characterization of the IRS-1 (insulin receptor substrate-1) gene and its promoter]. (1994) (4)
- Abstract 10718: Efficacy and Safety of K-877, a Potent and Selective PPAR-a Agonist, in Japanese Patients With Dyslipidemia (2013) (4)
- Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy. (2015) (4)
- [Regulation of insulin signaling and its disorder]. (2005) (3)
- 35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
- Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy (2019) (3)
- Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial (2019) (3)
- Impact of tissue macrophage proliferation on peripheral and systemic insulin resistance in obese mice with diabetes (2020) (3)
- A case of primary thyroid squamous cell cancer: transformation from benign tumour associated with chronic thyroiditis? (2009) (3)
- Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study. (2019) (3)
- [Characterization and expression of the insulin receptor gene and its promoter]. (1994) (3)
- Phosphatase protector alpha4 (α4) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling (2022) (3)
- Abstract 17336: Marked Increase of Plasma Fibroblast Growth Factor 21 in Dyslipidemic Patients Treated With K-877, a Novel Highly Potent and Specific Peroxisome Proliferator-Activated Receptor Alpha Agonist (2013) (2)
- Issue Information (2018) (2)
- A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum. (2020) (2)
- [Polymorphisms in insulin receptor substrate-1 (IRS-1) gene]. (2002) (2)
- Efficacy of Pemafibrate on Atherogenic Dyslipidemia: Results of a Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Compared with Placebo (2018) (2)
- Corrigendum to “Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein”[Atherosclerosis, 2004, 176 (2): 233–245] (2004) (2)
- Long-term Pemafibrate Treatment Was Well Tolerated in Patients with Dyslipidemia Including Those with Kidney Dysfunction (2018) (2)
- Author response for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with type 2 diabetes in a phase 3, open‐label, randomised trial" (2019) (2)
- The PREDICTIVETM Study: a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes—data from the Japan cohort (2012) (2)
- Validation of Particle Numbers of Lipoproteins by Gel Permeation Chromatography: Comparison with NMR Lipoprofile 2 (LipoScience) and Lipoprofile 3 (LabCorp) (2018) (2)
- Potential of Monocyte Count for the Assessment of Cardiovascular Disease (2017) (2)
- Evaluation of a new device for measurement of hemoglobin A1c for Japanese subjects (2013) (2)
- Clinical profiles of hyperglycemic crises: A single‐center retrospective study from Japan (2020) (2)
- [Risk factors of diabetic retinopathy and their treatment]. (2010) (2)
- Effects of Selective PPARα Modulator K-877 on Particle Numbers of Lipoprotein Subclasses in Dyslipidemic Patients: Analysis by GP-HPLC and NMR Lipoprofile 2 and 3 (2018) (2)
- Potent anti-obesity effect of acetate; acetate may alter the expression of genes involved in beige adipogenesis in obese KK-Ay mice (2016) (2)
- Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes (2022) (1)
- Cellular stress response pathways and diabetes mellitus (2015) (1)
- A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without Hyperthyroidism. (2018) (1)
- 1072-P: Activation of Heat Shock Response Ameliorates Nonalcoholic Fatty Liver Disease Biomarkers (2020) (1)
- [Polymorphisms of PPARs and metabolic disorders]. (2005) (1)
- Abstract: 624 OX-LDL ACTIVATES PPARΓ TROUGH MAPK-DEPENDENT COX-2 EXPRESSION IN MACROPHAGES (2009) (1)
- [RAAS and insulin resistance]. (2012) (1)
- [Kumamoto Study]. (2010) (1)
- Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma (2020) (1)
- 4P-0977 Extracellular signal-regulated kinase and p38 mitogen-activated protein kinases are involved in oxidized low density lipoprotein-induced macrophage proliferation (2003) (1)
- [A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration]. (2013) (1)
- Impacts of tight multifactorial intervention in patients with type 2 diabetes: Implications from the Japan Diabetes Outcome Intervention Trial 3 (2018) (1)
- Comparison of effects of 1-week and 2-week hospitalization training using critical paths in glycemic control in type 2 diabetes patients (2008) (1)
- Author response for "Long‐term (52‐week) efficacy and safety of dapagliflozin as adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT ‐2 study" (2020) (1)
- Impact of mitochondrial reactive oxygen species in the pathogenesis of aging and diabetes (2008) (1)
- The effect of mild electrical stimulation with heat shock on diabetic KKAy mice (2016) (1)
- New perspectives on insulin therapy (2020) (1)
- Activation of heat shock response improves biomarkers of NAFLD in patients with metabolic diseases (2021) (1)
- 1) Impacts of Anti-diabetic Drugs on Protection from Cardiovascular and Renal Diseases in Patients with Diabetes (2020) (1)
- Clinical Benefit of Switching from Low-Dose to High-Dose Empagliflozin in Patients with Type 2 Diabetes (2022) (1)
- FoxK1/K2 Are New, Important Components of IR and IGF1R Signaling and Control of Cell Proliferation and Metabolism (2018) (1)
- [Resistin and TNFalpha]. (2006) (1)
- Correction to: Japanese Clinical Practice Guideline for Diabetes 2016 (2018) (1)
- [Key notes of glycemic control in elderly patients with diabetes]. (2016) (1)
- [Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus]. (2002) (1)
- [Strategies for the prevention of elderly-onset type 2 diabetes mellitus]. (2006) (1)
- Significance of Circulating Remnant Lipoprotein Cholesterol Levels Measured by Homogeneous Assay in Patients with Type 2 Diabetes (2023) (0)
- Statins induce anti-atherosclerotic action in VSMCs through the activation of PPARγ (2011) (0)
- Progress in research on insulin action and development for network of diabetes care - Beyond remaining challenge of Kumamoto study (2013) (0)
- 482-P: Linagliptin Induces M2 Macrophage Polarization and Suppresses Progression of Atherosclerosis in High-Fat-Fed ApoE-Deficient Mice (2019) (0)
- [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Artificial endocrine pancreas]. (2002) (0)
- Abstract: P721 L-TYPE CALCIUM CHANNEL BLOCKER, AZELNIDIPINE SUPPRESSES OX-LDL-INDUCED MACROPHAGE PROLIFERATION (2009) (0)
- Molecular Mechanisms of Diabetic Retinopathy : Impact of Metabolic Disorders on Retinopathy (2010) (0)
- Issue Information (2014) (0)
- 142-OR: Unique Role of the a4 Component for S6-Kinase Activity in Metabolic Regulation and Anti-apoptotic Effect in Brown Adipose Tissue (2019) (0)
- [Programs for continuing medical education: a session; 6. New trends in diabetes treatment--actions and usages of anti-diabetic medicines]. (2013) (0)
- NEPHROGENIC DIABETES INSIPIDUS WITH A V2 RECEPTOR MUTATION AT A FUNCTIONALLY CRITICAL SITE (2005) (0)
- [Exercise, foods and bathing during insulin therapy]. (2002) (0)
- New classification and diagnostic criteria for insulin resistance syndrome. (2022) (0)
- [Treatment of diabetes mellitus based on EBM]. (2007) (0)
- A Case of Factitious Hypoglycemia Diagnosed by High Performance Liquid Chromatography (HPLC) (1990) (0)
- Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin (DAPA) in Combination with Insulin in Japanese Patients with T1D (2018) (0)
- 3P-0704 Oxidized low density lipoprotein-induced macrophage proliferation was inhibited by 15-deoxy prostaglandin J2 via inactivation of NF-kB and induces macrophage apoptosis (2003) (0)
- [Clinical application of exenatide in Japanese patients with type 2 diabetes mellitus]. (2011) (0)
- Issue information (2019) (0)
- Issue Information (2017) (0)
- [Glycated lipoproteins]. (2002) (0)
- Post-challenge blood glucose levels after oral glucose tolerance tests correlated with pulse wave velocity and risk of coronary heart disease (2004) (0)
- Impacts of the Kumamoto Earthquake 2016 on Glycemic Control in Diabetic Patients (2018) (0)
- [The mechanism of action of antidiabetic drugs]. (2015) (0)
- HbA1c: The lower the better? (2010) (0)
- PO024 ASSOCIATION BETWEEN CIRCULATING LEUKOCYTE SUBTYPE COUNTS AND CAROTID INTIMA-MEDIA THICKNESS IN JAPANESE SUBJECTS WITH TYPE 2 DIABETES (2014) (0)
- Activation of heat shock response improves glucose metabolism and inflammation in obese subjects with type 2 diabetes (2016) (0)
- Issue Information (2014) (0)
- Dietary intake and physical activity in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 8) (2022) (0)
- [Type A or type B syndrome of insulin resistance]. (2006) (0)
- Issue Information (2019) (0)
- Development and clinical application of artificial endocrine pancreas; present status (2002) (0)
- A case of alkalemia accompanied by diabetic ketoacidosis in a patient with glucocorticoid-induced diabetes mellitus (2015) (0)
- [Molecular mechanisms that involve the development and progression of type 2 diabetes]. (2012) (0)
- Study Design of a Phase II Clinical Trial to Assess the Efficacy and Safety of Eperisone in Japanese Type 2 Diabetes Patients with Risk and Non-risk Alleles of CDKAL1. (2018) (0)
- 483-P: Pioglitazone Suppresses Macrophage Proliferation in Apolipoprotein-e Deficient Mice by Activating PPARγ (2019) (0)
- 8. Recent Advances in the Treatment of Diabetes (2018) (0)
- [Long-term clinical application of wearable artificial endocrine pancreas]. (2002) (0)
- Issue Information (2015) (0)
- [Application and practice of intensive insulin therapy]. (2002) (0)
- A case of gestational diabetes insipidus successfully treated during the management for threatened preterm delivery (2016) (0)
- Issue Information (2015) (0)
- Issue Information (2016) (0)
- Issue Information (2014) (0)
- Issue Information (2014) (0)
- [Abnormal lipid metabolism--paraneoplastic syndromes---statistics and etiological mechanism]. (1980) (0)
- Issue Information (2017) (0)
- Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model (2020) (0)
- 1863-P: The Hepatic Role of Heat Shock Protein 72 in the Pathogenesis of Type 2 Diabetes (2019) (0)
- 721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8 (2022) (0)
- Issue Information (2017) (0)
- Obese IRS-1(±) mice as a model for type 2 diabetes (2000) (0)
- Issue Information (2016) (0)
- Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis (2022) (0)
- Issue Information (2016) (0)
- Effectiveness of miglitol combined with various types of insulin therapy for reducing the daily glycemic fluctuation on Japanese type 2 diabetic patients: Evaluation with self-monitoring blood glucose (SMBG) (2013) (0)
- Issue Information (2018) (0)
- Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes (2020) (0)
- Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoE-deficient mice (2016) (0)
- Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report (2022) (0)
- Erratum to: Evaluation of a new device for measurement of hemoglobin A1c for Japanese subjects (2013) (0)
- [Risk factors of diabetic retinopathy and their control]. (2005) (0)
- Issue Information (2016) (0)
- Inhibition of local macrophage growth ameliorates obesity-associated adipose tissue inflammation, insulin resistance and hepatic steatosis in HFD-fed mice (2016) (0)
- An observational study of diabetes outpatients switching from glargine or detemir to degludec (2016) (0)
- [Role of oxidative stress in pathogenesis of diabetic microangiopathies]. (2005) (0)
- Issue Information (2019) (0)
- Issue Information (2014) (0)
- Issue Information (2016) (0)
- 1714-P: Regulation of Phosphorylation Status in Insulin Signaling via a4 Is Necessary for Adipocyte Maintenance and Lipid Dynamics (2020) (0)
- Abstract 12384: Novel Approach to Residual Risk, K-877, a Potent and Selective PPAR-α Modulator (SPPARMα), Added-on to Pitavastatin in Japanese Patients With Dyslipidemia (2015) (0)
- Updates of incretin‐related drugs for the treatment of type 2 diabetes (2022) (0)
- Abstract: P719 NIFEDIPINE SUPPRESSES THE PROGRESSION OF ATHEROSCLEROSIS THROUGH THE ACTIVATION OF PPARΓ (2009) (0)
- 4) Novel Insight into Obesity Disease-Development of Treatment Employing the Modulation of Intracellular Stress Response Pathways (2016) (0)
- Abstract: P981 STATINS MEDIATE ANTI-ATHEROSCLEROTIC EFFECT VIA PPARΓ ACTIVATION IN MACROPHAGES (2009) (0)
- 4. Molecular Analysis of the Pathophysiology of Diabetes and Its Complications for the Development of Novel Diabetes Therapeutics (2022) (0)
- Pharmacotherapeutic Options for the Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes (2012) (0)
- LSD1 defines the fiber type-selective responsiveness to environmental stress in skeletal muscle (2023) (0)
- Issue Information (2017) (0)
- LSD1 acts as an epigenetic barrier against glucocorticoid-induced atrophy and exercise-induced hypertrophy in skeletal muscle (2022) (0)
- Issue Information (2016) (0)
- DEVELOPMENT OF CLOSED-LOOP INTRAPERITONEAL INSULIN INFUSION ALGORITHM FOR AN ARTIFICIAL ENDOCRINE PANCREAS (2003) (0)
- [Clinical courses of two male siblings on hemodialysis for Fabry disease ]. (2005) (0)
- Issue Information (2017) (0)
- Erratum: Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes. Insulin secretion in response to physiological concentrations of glucose (Diabetologia (1998) 41 (1492-1501)) (1999) (0)
- [Resistin, TNF-alpha, PAI-1]. (2011) (0)
- Issue Information (2016) (0)
- [The study of development and progression of long-term complications in type I diabetes]. (2002) (0)
- Clinical courses of two male siblings with Fabry disease on hemodialysis (2005) (0)
- ANIMAL MODELS OF IRS-1/IRS-2 KNOCKOUTS (2002) (0)
- Report of committee on early-onset type 2 diabetes mellitus - Preliminary research on actual situation of early-onset type 2 diabetes mellitus (2008) (0)
- [Inhibitory effects of somatostatin analog (SMS 201-995) on pancreatic hormones in patients with malignant islet-cell carcinoma]. (1988) (0)
- [Response to diabetic emergencies. 2. Sick days]. (2000) (0)
- FoxK1 and FoxK2 are positive regulators for IR and IGF1R signalling in cell proliferation and metabolism (2019) (0)
- Economic impact of multiple insulin injection therapy for type 2 diabetic patients (2000) (0)
- [Implantable artificial endocrine pancreas]. (2002) (0)
- 1956-P: Inhibition of Tissue Macrophage Proliferation Improves Insulin Resistance in Liver and Adipose Tissue (2020) (0)
- Issue Information (2017) (0)
- Regulation ofInsulin Receptor Substrate-1 inLiver andMuscleofAnimalModelsofInsulin Resistance (1992) (0)
- PDB64 - SHORT-TERM COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC IN JAPANESE PATIENTS WITH TYPE 2 DIABETES (2018) (0)
- Molecular analysis of insulin signal transduction system: Analysis of the function and regulation of the insulin receptor and its substrate IRS-1 (1997) (0)
- A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Showed No Significant Increase in Incidence of Adverse Events Compared with Placebo (2018) (0)
- [The expression of the insulin receptor substrate-1 (IRS-1) and analysis of its mechanism]. (1995) (0)
- [113th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Insight into the Mechanism of Diseases on New Perspective Arising in Internal Medicine: From Epigenetics to Organ Associations: Introduction]. (2016) (0)
- PO350 STATIN-MEDIATED PPAR-GAMMA ACTIVATION IN ADIPOCYTES MAY IMPROVE GLUCOSE TOLERANCE IN HIGH FAT-FED MICE (2014) (0)
- 29-OR: Regulatory Loop of IR Signaling for Adipocyte Mitochondrial Homeostasis (2021) (0)
- SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice (2022) (0)
- FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism (2019) (0)
- Correction to: Japanese Clinical Practice Guideline for Diabetes 2016 (2019) (0)
- [Future of ultra long-acting insulin analogues]. (2015) (0)
- Replacement oflysine residue 1030intheputative ATP-binding region oftheinsulin receptor abolishes insulin- and antibody-stimulated glucose uptake andreceptor kinase activity (tyrosine kinase/insulin action) (1987) (0)
- The Amount of Residual Incretin Regulates the Pancreatic β-cell Function and Glucose Homeostasis (2021) (0)
- Issue Information (2018) (0)
- Issue Information (2014) (0)
- Issue Information (2015) (0)
- Issue Information (2018) (0)
- Issue Information (2018) (0)
- [Trends in drug development for diabetic retinopathy]. (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eiichi Araki?
Eiichi Araki is affiliated with the following schools:
